β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio

<p>Abstract</p> <p>Background</p> <p>β-1→3-D-glucans represent a pathogen-associated molecular pattern and are able to modify biological responses. Employing a comprehensive methodological approach, the aim of our <it>in vitro </it>study was to elucidate nov...

Full description

Bibliographic Details
Main Authors: Koritke Petra, Rink Lothar, Hennig Holger, Brand Joerg M, Frohn Christoph, Hensel Jenny, Langenkamp Ulrich, Luhm Juergen, Wittkopf Nadine, Williams David L, Mueller Antje
Format: Article
Language:English
Published: BMC 2006-03-01
Series:BMC Immunology
Online Access:http://www.biomedcentral.com/1471-2172/7/5
id doaj-dca6272943254b30b504633950c2b802
record_format Article
spelling doaj-dca6272943254b30b504633950c2b8022020-11-25T03:57:33ZengBMCBMC Immunology1471-21722006-03-0171510.1186/1471-2172-7-5β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratioKoritke PetraRink LotharHennig HolgerBrand Joerg MFrohn ChristophHensel JennyLangenkamp UlrichLuhm JuergenWittkopf NadineWilliams David LMueller Antje<p>Abstract</p> <p>Background</p> <p>β-1→3-D-glucans represent a pathogen-associated molecular pattern and are able to modify biological responses. Employing a comprehensive methodological approach, the aim of our <it>in vitro </it>study was to elucidate novel molecular and cellular mechanisms of human peripheral blood immune cells mediated by a fungal β-1→3-D-glucan, <it>i.e</it>. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).</p> <p>Results</p> <p>Despite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 and NFAT similar to LPS or TSST-1, we observed no significant production of IL-1β, IL-6, tumor necrosis factor α or interferon γ induced by glucan phosphate. Glucan phosphate-treated leukocytes induced a substantial amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL-8 levels. Glucan phosphate induced significant binding to a known NFIL-6 site and a new NFAT site within the IL-1RA promoter, which was confirmed by inhibition experiments. When applied in combination with either LPS or TSST-1 at the same time points, we detected that glucan phosphate elevated the LPS- and the TSST-1-induced DNA binding of NFκB, NFIL-6 and NFAT, leading to a synergistic increase of IL-1RA. Further, glucan phosphate modulated the TSST-1-induced inflammatory response via reduction of IL-1β and IL-6. As a consequence, glucan phosphate shifted the TSST-1-induced IL-1β/IL-1RA ratio towards an anti-inflammatory phenotype. Subsequently, glucan phosphate decreased the TSST-1-induced, IL-1-dependent production of IL-2.</p> <p>Conclusion</p> <p>Thus, β-1→3-D-glucans may induce beneficial effects in the presence of pro-inflammatory responses, downstream of receptor binding and signaling by switching a pro- to an anti-inflammatory IL-1RA-mediated reaction. Our results also offer new insights into the complex regulation of the IL-1RA gene, which can be modulated by a β-1→3-D-glucan.</p> http://www.biomedcentral.com/1471-2172/7/5
collection DOAJ
language English
format Article
sources DOAJ
author Koritke Petra
Rink Lothar
Hennig Holger
Brand Joerg M
Frohn Christoph
Hensel Jenny
Langenkamp Ulrich
Luhm Juergen
Wittkopf Nadine
Williams David L
Mueller Antje
spellingShingle Koritke Petra
Rink Lothar
Hennig Holger
Brand Joerg M
Frohn Christoph
Hensel Jenny
Langenkamp Ulrich
Luhm Juergen
Wittkopf Nadine
Williams David L
Mueller Antje
β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
BMC Immunology
author_facet Koritke Petra
Rink Lothar
Hennig Holger
Brand Joerg M
Frohn Christoph
Hensel Jenny
Langenkamp Ulrich
Luhm Juergen
Wittkopf Nadine
Williams David L
Mueller Antje
author_sort Koritke Petra
title β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
title_short β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
title_full β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
title_fullStr β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
title_full_unstemmed β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio
title_sort β-(1→3)-d-glucan modulates dna binding of nuclear factors κb, at and il-6 leading to an anti-inflammatory shift of the il-1β/il-1 receptor antagonist ratio
publisher BMC
series BMC Immunology
issn 1471-2172
publishDate 2006-03-01
description <p>Abstract</p> <p>Background</p> <p>β-1→3-D-glucans represent a pathogen-associated molecular pattern and are able to modify biological responses. Employing a comprehensive methodological approach, the aim of our <it>in vitro </it>study was to elucidate novel molecular and cellular mechanisms of human peripheral blood immune cells mediated by a fungal β-1→3-D-glucan, <it>i.e</it>. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).</p> <p>Results</p> <p>Despite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 and NFAT similar to LPS or TSST-1, we observed no significant production of IL-1β, IL-6, tumor necrosis factor α or interferon γ induced by glucan phosphate. Glucan phosphate-treated leukocytes induced a substantial amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL-8 levels. Glucan phosphate induced significant binding to a known NFIL-6 site and a new NFAT site within the IL-1RA promoter, which was confirmed by inhibition experiments. When applied in combination with either LPS or TSST-1 at the same time points, we detected that glucan phosphate elevated the LPS- and the TSST-1-induced DNA binding of NFκB, NFIL-6 and NFAT, leading to a synergistic increase of IL-1RA. Further, glucan phosphate modulated the TSST-1-induced inflammatory response via reduction of IL-1β and IL-6. As a consequence, glucan phosphate shifted the TSST-1-induced IL-1β/IL-1RA ratio towards an anti-inflammatory phenotype. Subsequently, glucan phosphate decreased the TSST-1-induced, IL-1-dependent production of IL-2.</p> <p>Conclusion</p> <p>Thus, β-1→3-D-glucans may induce beneficial effects in the presence of pro-inflammatory responses, downstream of receptor binding and signaling by switching a pro- to an anti-inflammatory IL-1RA-mediated reaction. Our results also offer new insights into the complex regulation of the IL-1RA gene, which can be modulated by a β-1→3-D-glucan.</p>
url http://www.biomedcentral.com/1471-2172/7/5
work_keys_str_mv AT koritkepetra b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT rinklothar b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT hennigholger b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT brandjoergm b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT frohnchristoph b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT henseljenny b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT langenkampulrich b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT luhmjuergen b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT wittkopfnadine b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT williamsdavidl b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
AT muellerantje b13dglucanmodulatesdnabindingofnuclearfactorskbatandil6leadingtoanantiinflammatoryshiftoftheil1bil1receptorantagonistratio
_version_ 1724460221312532480